Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
General23 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General20 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General17 hours agoRegional house price growth outstrips capital cities
-
General14 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore